Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search

Thrombin

Citations 21-30 of 36 total displayed.

Past content (since Jul 2001):

Emerging Therapies
Direct Thrombin Inhibition: A Novel Approach to Stroke Prevention in Patients With Atrial Fibrillation
Mitchell S.V. Elkind and Ralph L. Sacco
Stroke 2004;35:1519-1522; published online before print as doi:10.1161/01.STR.0000128883.89984.52 [Full text]  

Articles
Argatroban Anticoagulation in Patients With Acute Ischemic Stroke (ARGIS-1). A Randomized, Placebo-Controlled Safety Study
Marian P. LaMonte, Marshall L. Nash, David Z. Wang, Andrew R. Woolfenden, John Schultz, Marcie J. Hursting, Philip M. Brown for the ARGIS-1 Investigators
Stroke published May 20, 2004, doi:10.1161/01.STR.0000131549.20581.ba [Abstract]  

Articles
Direct Thrombin Inhibition. A Novel Approach to Stroke Prevention in Patients With Atrial Fibrillation
Mitchell S.V. Elkind and Ralph L. Sacco
Stroke published May 13, 2004, doi:10.1161/01.STR.0000128883.89984.52 [Abstract]  

Original Contributions
Prothrombin Fragment 1+2 Is Associated With Carotid Intima-Media Thickness in Subjects Free of Clinical Cardiovascular Disease
J.A. Páramo, J. Orbe, O. Beloqui, A. Benito, I. Colina, E. Martinez-Vila, and J. Diez
Stroke 2004;35:1085-1089; published online before print as doi:10.1161/01.STR.0000124927.38723.f2 [Abstract] [Full text]  

Articles
Hemostatic Function and Progressing Ischemic Stroke: D-dimer Predicts Early Clinical Progression
Mark Barber, Peter Langhorne, Ann Rumley, Gordon D.O. Lowe, and David J. Stott
Stroke published April 8, 2004, doi:10.1161/01.STR.0000126890.63512.41 [Abstract]  

Articles
Prothrombin Fragment 1+2 Is Associated With Carotid Intima-Media Thickness in Subjects Free of Clinical Cardiovascular Disease
J. A. Páramo, J. Orbe, O. Beloqui, A. Benito, I. Colina, E. Martinez-Vila, and J. Diez
Stroke published March 11, 2004, doi:10.1161/01.STR.0000124927.38723.f2 [Abstract]  

Original Contributions
Differences in Clot Preparation Determine Outcome of Recombinant Tissue Plasminogen Activator Treatment in Experimental Thromboembolic Stroke
Frank Niessen, Thomas Hilger, Mathias Hoehn, and Konstantin-A. Hossmann
Stroke 2003;34:2019-2024; published online before print as doi:10.1161/01.STR.0000080941.73934.30 [Abstract] [Full text]  

Articles
Differences in Clot Preparation Determine Outcome of Recombinant Tissue Plasminogen Activator Treatment in Experimental Thromboembolic Stroke
Frank Niessen, Thomas Hilger, Mathias Hoehn, and Konstantin-A. Hossmann
Stroke published July 3, 2003, doi:10.1161/01.STR.0000080941.73934.30 [Abstract]  

Original Contributions
Is Thrombogenesis in Atrial Fibrillation Related to Matrix Metalloproteinase-1 and Its Inhibitor, TIMP-1?
Francisco Marín, Vanessa Roldán, Vicente Climent, Amaya García, Pascual Marco, and Gregory Y.H. Lip
Stroke 2003;34:1181-1186; published online before print as doi:10.1161/01.STR.0000065431.76788.D9 [Abstract] [Full text]  

Research Reports
Thrombin-Activable Fibrinolysis Inhibitor Levels in the Acute Phase of Ischemic Stroke
Joan Montaner, Marc Ribó, Jasone Monasterio, Carlos A. Molina, and José Alvarez-Sabín
Stroke 2003;34:1038-1040; published online before print as doi:10.1161/01.STR.0000063139.06585.45 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4

* Subspecialty Collections Home

* Show  Thrombin
 collections from other journals.

* Related collections:
 Thrombosis
 Anticoagulant mechanisms
 Anticoagulants
 Arterial thrombosis
 Coagulation and fibronolysis
 Coagulation inhibitors
 Coagulation
 Deep vein thrombosis
 Fibrinogen/fibrin
 Fibrinolysis
 Platelet adhesion
 Platelet function inhibitors
 Platelets
 Thrombin
 Thrombophilia
 Thrombosis risk factors